MicroRNA 5088 (MIR5088)

MicroRNA 5088 (MIR5088) is listed as a human microRNA in sequence annotation databases and included in updated miRBase versions[5], but there is no published research describing its biological function, disease association, target genes, or relevance as a therapeutic target. MicroRNAs (miRNAs) in general are short (about 20–23 nucleotides) non-coding RNAs that regulate gene expression post-transcriptionally by binding to complementary sequences, typically in the 3′ UTR of mRNAs, leading to translation repression or decay[2][3][4][5]. However, for MIR5088, there is a lack of evidence of its functional relevance, disease association, or involvement in any therapeutically actionable pathways, suggesting that it may be a computationally predicted sequence without experimental validation[5]. Several hundred human miRNAs are annotated by sequence characteristics and conservation rather than functional characterization[5]. Many annotated miRNAs lack supporting experimental evidence; MIR5088 appears to be among these, with no robust literature supporting its biological or clinical relevance[5]. MIR5088 is not referenced in review articles or functional studies about major microRNAs involved in gene regulation or disease[1][2][3][4][5]. In summary, MicroRNA 5088 (MIR5088) is not a validated therapeutic target; its sequence is annotated, but there is no known biological, disease, or pharmacological function. This entry is likely incomplete or represents a computationally predicted miRNA rather than an experimentally confirmed regulator or disease target[5].

Other names

hsa-mir-5088mir-5088MIR5088